NHS receives extra £5.4 billion to support COVID-19 response over next 6 months
The Prime Minister and Health and Social Care Secretary Sajid Javid have announced that the NHS will receive an extra £5.4 billion over the...
Patient management in a digital world
It is well established that the COVID-19 pandemic accelerated the digital evolution of the NHS by years in a matter of weeks, resulting in...
Patient pathways: Tracing a collaborative path to high quality care
Faced with the monumental challenge of COVID-19, health and social care staff moved into crisis mode, reorganising, recalibrating, and realigning to meet the demands...
CMA warns PCR COVID-19 test providers against breaching consumer law
The CMA has sent an open letter to PCR COVID-19 test providers warning that a range of harmful practices in the sector could breach...
NHS reports increase in diabetes drug prescriptions
A new NHS report shows an increase in diabetes drug prescriptions. It concludes that diabetes drugs prescribed increased by 8 million since 2015/16. NHS Business...
Negotiating the changing NHS landscape: five critical shifts the pharma industry must embrace
As the long-awaited Health and Care Bill begins its passage through parliament, Oli Hudson looks at five critical changes resulting from these reforms that...
Setting the scene: sarcoma diagnosis and treatment
July marks Sarcoma Awareness Month and the 10th anniversary of the bone and soft tissue cancer charity, Sarcoma UK. To mark their anniversary, the...
Genetic variants identified that impact immune cells’ functioning
Genetic variants have been identified that impact immune cells' functioning. Certain genetic variants that cause modified protein binding in immune cells, are also seen...
New transatlantic cancer research partnership
The two largest funders of cancer research in the world are set to make radical progress against cancer with a new scientific cancer research...
Pancreatic Cancer Story: John William Street
Pancreatic cancer is the 10th most common cancer in the UK, with around 10,000 people diagnosed each year. The disease has the lowest survival...
Latest articles
EC grants marketing authorisation for breast cancer treatment Trodelvy
The European Commission (EC) has granted marketing authorization for Gilead Sciences’ Trodelvy® (sacituzumab govitecan), as a monotherapy indicated for the treatment of adult patients with...
Nykode Therapeutics partners with Regeneron to develop innovative vaccines
Nykode Therapeutics (formerly Vaccibody) has entered into a collaboration agreement with Regeneron to develop innovative vaccines against cancer and infectious diseases. The agreement includes five...
New depression treatment options from NICE
The National Institute for Health and Care Excellence (NICE) has created a new menu of treatment options for those living with depression. It is the...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
A CLASS DIVIDED – A LIFE CHANGING EXPERIMENT
What can your team learn about positive thinking from a schoolteacher in the 1970s and a world heavy weight champion? Ama Verdi-Ashton explains. It...
Does great brand planning make the difference?
As the hot summer days begin to fade behind us, thoughts start to turn towards next year. Teams are ramping up their planning activities...
Four rooms of change: managing transition
For the UK pharma industry, 2010 is likely to bring change in various forms. How will you cope? OTD’s Andy Cotty explains how, with...
New COVID-19 test reduces testing time from 30 minutes to five
University of Birmingham researchers have invented a COVID-19 test that reduces testing time from 30 minutes to under five, whilst still delivering accurate results. The...